Rumeng Pan
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Polarity protein MALS3 suppresses breast cancer stem cell-like properties by promoting TAZ inactivation and ubiquitination-dependent degradation.
Journal: Cell death & disease
Published: January 22, 2026
Characterization of the prognostic, diagnostic, and immunological roles of DSCC1 and its genomic alteration and instability in human cancers.
Journal: Cellular and molecular biology (Noisy-le-Grand, France)
Published: January 12, 2024
FGF2 promotes the proliferation of injured granulosa cells in premature ovarian failure via Hippo-YAP signaling pathway.
Journal: Molecular and cellular endocrinology
Published: January 10, 2024
From genomic spectrum of NTRK genes to adverse effects of its inhibitors, a comprehensive genome-based and real-world pharmacovigilance analysis.
Journal: Frontiers in pharmacology
Published: October 30, 2023
FGF2 Rescued Cisplatin-Injured Granulosa Cells through the NRF2-Autophagy Pathway.
Journal: International journal of molecular sciences
Published: July 30, 2023
A pharmacovigilance study of etoposide in the FDA adverse event reporting system (FAERS) database, what does the real world say?
Journal: Frontiers in pharmacology
Published: July 17, 2023
Endometrial stem cells alleviate cisplatin-induced ferroptosis of granulosa cells by regulating Nrf2 expression.
Journal: Reproductive biology and endocrinology : RB&E
Published: July 17, 2023
Integrative bioinformatics analysis of WDHD1: a potential biomarker for pan-cancer prognosis, diagnosis, and immunotherapy.
Journal: World journal of surgical oncology
Published: February 04, 2023
Showing 1-9 of 9
Last Updated: 09/26/2026